Inactive Instrument

Golden Meditech Holdings Limited Stock

801 KYG395801247

Medical Equipment, Supplies & Distribution

Latest news : Golden Meditech Holdings Limited

20-06-30	Golden Meditech Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2020	CI
19-11-27	Golden Meditech Holdings Limited Reports Earnings Results for the Six Months Ended September 30, 2019	CI
19-09-23	Golden Meditech Holdings Limited(SEHK:801) dropped from S&P Global BMI Index	CI
19-06-28	Golden Meditech Holdings Limited Reports Earnings Result for the Year Ended March 31, 2019	CI
19-06-03	Golden Meditech Holdings Limited Provides Unaudited Earnings Guidance for the Year Ended March 31, 2019	CI
19-05-24	Golden Meditech Holdings Limited Announces Management Changes	CI
19-04-17	Golden Meditech Holdings Limited and Hong Kong Baptist University Team Up to Conduct Cell Therapy Research	CI
18-11-26	Golden Meditech Holdings Limited Announces Earnings Results for the Six Months Ended September 30, 2018	CI
18-06-27	Golden Meditech Holdings Limited Announces Group Earnings Results for the Year Ended March 31, 2018	CI
18-06-25	Golden Meditech Holdings Limited Provides Earnings Guidance for the Year Ended 31 March 2018	CI
18-04-26	Golden Meditech Holdings Limited Announces Board Changes	CI
18-02-13	Golden Meditech Holdings Limited Declares Special Dividend, Payable on or around 26 March 2018	CI
18-02-01	Tranche Update on Golden Meditech Holdings Limited's Equity Buyback Plan announced on October 30, 2017.	CI

More news

Press Releases : Golden Meditech Holdings Limited

20-09-18	Golden Meditech : JOINT ANNOUNCEMENT PROPOSAL FOR THE PRIVATISATION OF GOLDEN MEDITECH HOLDINGS LIMITED BY THE OFFEROR BY WAY OF A SCHEME OF ARRANGEMENT (UNDER SECTION 86 OF THE COMPANIES LAW) COMPLETION OF 2ND TRANCHE SUBSCRIPTION	PU
20-09-17	Golden Meditech : CHANGE IN BOARD LOT SIZE	PU
20-09-16	Golden Meditech : JOINT ANNOUNCEMENT ON (1) PROPOSAL FOR THE PRIVATISATION OF GOLDEN MEDITECH HOLDINGS LIMITED BY THE OFFEROR BY WAY OF A SCHEME OF ARRANGEMENT (UNDER SECTION 86 OF THE COMPANIES LAW) (2) PROPOSED WITHDRAWAL OF LISTING (3) RESULTS OF THE COURT MEETING AND THE GENERAL MEETING AND (4) CLOSURE OF REGISTER OF MEMBERS	PU
20-08-21	Golden Meditech : JOINT ANNOUNCEMENT - (1) DESPATCH OF SCHEME DOCUMENT IN RELATION TO THE PROPOSAL FOR THE PRIVATISATION OF GOLDEN MEDITECH HOLDINGS LIMITED BY THE OFFEROR BY WAY OF A SCHEME OF ARRANGEMENT (UNDER SECTION 86 OF THE COMPANIES LAW) AND (2) COMPLETION OF 1ST TRANCHE SUBSCRIPTION	PU
20-08-20	Golden Meditech : NOTICE OF GENERAL MEETING	PU

More press releases

Managers and Directors : Golden Meditech Holdings Limited

Manager	Title	Age	Since
Cheuk Man Lam SEC	Corporate Secretary	42	2019-05-23
Fan Huang PRN	Corporate Officer/Principal	52	-
Jian Zhong Jing PRN	Corporate Officer/Principal	72	-

Director	Title	Age	Since
Wen Feng CHM	Chairman	57	2019-05-23
Yue Gao BRD	Director/Board Member	53	-
Daniel Foa BRD	Director/Board Member	49	2016-02-10

More insiders

Other Medical Equipment, Supplies & Distribution

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
GOLDEN MEDITECH HOLDINGS LIMITED	-.--%	-.--%	-	-	327M
ABBOTT LABORATORIES	+1.41%	-3.18%	-15.97%	+7.41%	188B
MEDTRONIC PLC	+0.15%	+0.17%	-1.23%	+12.24%	118B
CENCORA, INC.	+1.63%	+2.61%	+14.08%	+92.25%	63.16B
HOYA CORPORATION	-0.96%	-1.14%	+23.87%	+47.11%	52.01B
BECTON, DICKINSON AND COMPANY	+0.21%	-1.41%	-0.33%	-32.66%	50.97B
DEXCOM, INC.	-0.50%	+0.82%	+20.71%	-11.98%	34.02B
MEDLINE INC.	+3.39%	+4.97%	-	-	30.8B
WEST PHARMACEUTICAL SERVICES, INC.	+1.18%	-2.08%	+40.57%	-15.96%	23.83B
TERUMO CORPORATION	+0.57%	-3.01%	-5.66%	+14.32%	23.45B
Average	+0.66%	-0.49%	+9.50%	+14.09%	64.95B
Weighted average by Cap.	+0.72%	-1.72%	+0.90%	+16.25%

See all sector performances

Golden Meditech Holdings Limited is a Hong Kong-based investment holding company principally engaged in medical businesses. The Company operates through four segments. Medical Devices segment is engaged in the development, manufacture and sales of medical devices and medical accessories. Hospital Management segment is engaged in the provision of hospital management services and hospital operation in China. Its hospitals include Beijing Qinghe Hospital and Shanghai East International Medical Center. Medical Insurance Administration segment is engaged in the provision of medical insurance administration services in China. Chinese Herbal Medicines segment is engaged in the research and development, manufacture and sales of Chinese herbal medicines.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company